NIKA PHARMACEUTICALS, INC (NIKA)
About NIKA PHARMACEUTICALS, INC
NIKA PHARMACEUTICALS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $0
- Net income
- -$76.4K
- Total assets
- $21.0K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Nika Pharmaceuticals, Inc (NIKA) Stock Price
- Reported a net loss of $76.4K in FY2024.
- Trading 20% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NIKA PHARMACEUTICALS, INC.
Write a review
News about NIKA PHARMACEUTICALS, INC
News & sentiment via Polygon.io
Nika Pharmaceuticals, Inc: frequently asked questions
Is Nika Pharmaceuticals, Inc an American company?
Nika Pharmaceuticals, Inc is a US-based company headquartered in Henderson, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Nika Pharmaceuticals, Inc headquartered?
Nika Pharmaceuticals, Inc is headquartered in Henderson, Nevada, United States.
Is Nika Pharmaceuticals, Inc publicly traded?
Yes — Nika Pharmaceuticals, Inc is a publicly traded company. Its stock trades under the ticker symbol NIKA on the OTC.
What does Nika Pharmaceuticals, Inc do?
Nika Pharmaceuticals, Inc is an American Pharmaceuticals company in the Health & Beauty sector.
